CRO Viva raises $193.9 million in Hong Kong IPO

Viva will begin trading Thursday after raising HK$1.5 billion (US$193.9 million) early Wednesday in an IPO that values the drug discovery services company at HK$6.6 billion (US$843.1 million).

Viva Biotech Holdings (HKSE:1873) sold 345 million shares at

Read the full 360 word article

How to gain access

Continue reading with a
two-week free trial.